Mithra - Letter to Shareholders and Corporate Update
May 25, 2023 01:30 ET
|
Mithra Pharmaceuticals
Letter to Shareholders and Corporate Update Access to EUR15 million under amended dealDonesta® U.S. marketing deal is a key near term priorityCDMO strategic options are being exploredDonesta®...
Mithra - Letter to Shareholders and Corporate Update
May 25, 2023 01:30 ET
|
Mithra Pharmaceuticals
Letter to Shareholders and Corporate Update Access to EUR15 million under amended dealDonesta® U.S. marketing deal is a key near term priorityCDMO strategic options are being exploredDonesta®...
Atlas Salt Corporate Update
May 18, 2023 16:10 ET
|
Atlas Salt Inc.
ST. JOHN'S, Newfoundland and Labrador, May 18, 2023 (GLOBE NEWSWIRE) -- Atlas Salt (the “Company” or “Atlas” - TSXV: SALT; OTCQB: REMRF; FSE: 9D00), 100% owner of North America’s premier...
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2023
May 04, 2023 16:07 ET
|
LifeVantage Corporation
SALT LAKE CITY, May 04, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its third fiscal quarter ended March 31, 2023. Third Quarter Fiscal 2023...
Veru Enters into Common Stock Purchase Agreement for Up to $100 Million with Lincoln Park Capital
May 03, 2023 08:30 ET
|
Veru Inc.
MIAMI, FL, May 03, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for...
Birchtree Investments Ltd. Provides Corporate Update
April 28, 2023 18:02 ET
|
Birchtree Investments Ltd.
VANCOUVER, British Columbia, April 28, 2023 (GLOBE NEWSWIRE) -- Birchtree Investments Ltd. (“Birchtree” or the “Company”) (CSE: BRCH), an investment company with the long-term goal of divesting its...
AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update
April 28, 2023 07:00 ET
|
AC Immune SA
AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update ACI-24.060 anti-Abeta vaccine showed positive initial safety and immunogenicity in first Alzheimer’s disease...
Tiziana Life Sciences Ltd Reports Annual Results for the Twelve Months Ended December 31, 2022, and Corporate Update
April 26, 2023 14:47 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Streamline Health® To Report Fourth Quarter and Fiscal Year 2022 Financial Performance and Provide Corporate Update
April 19, 2023 16:30 ET
|
Streamline Health Solutions, Inc.
Atlanta, GA, April 19, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to...
Osisko Announces Preliminary Q1 2023 Deliveries and Provides Company Update
April 06, 2023 08:00 ET
|
Osisko Gold Royalties Ltd.
MONTRÉAL, April 06, 2023 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) is pleased to provide an update on its first quarter 2023 deliveries,...